多巴

duō bā
  • dopa;dihydroxyphenylalanine
多巴多巴
  1. 结论:培养的大量细胞可用于RPE的体外实验研究,多巴染色是鉴定RPE细胞一种较好的方法。

    Conclusion : We can produce a large quantity of RPE cells for in vitro experiments and DOPA staining proves effective in identification of RPE cells .

  2. 治疗组32例,运用眼针疗法,再结合常规剂量的美多巴(madopar)治疗。

    Treatment group of 32 patients using eye-acupuncture therapy , in combination with conventional doses of the United States dopa treatment .

  3. 美多巴B族维生素浓度对帕金森患者同型半胱氨酸的影响

    The effect of Madopar and vitamin B on plasma homocysteine in patients with Parkinson diease

  4. 中国人常染色体隐性遗传性多巴反应性肌张力障碍TH基因突变分析

    TH gene mutation in Chinese patients with autosomal recessive dopa-responsive dystonia

  5. 方法将6羟基多巴(6OHDA)注入大鼠纹状体内制作PD动物模型。

    Methods Rat models of PD were made by injection 6-hydroxydopamine ( 6-OHDA ) into striatum .

  6. 美多巴治疗后P1波潜伏时缩短、振幅增高(P<0.05)。

    Through detecting PVEP during the treatment of amblyopia with Madopar , we found P1 latency shortened and amplitude increased ( P < 0 . 05 ) .

  7. 未用多巴类药物的患者针刺前DA含量均低于健康人。

    The DA content in urine of patients before acupuncture was less than healthy ones .

  8. 多巴资本(TobaCapital)风险投资合伙人帕特里克•马西森的回答

    Answer by Patrick Mathieson , VC Associate at Toba Capital

  9. 结论低蛋白饮食方法有助于PD患者长期服用美多巴治疗。

    Conclusion Low - protein diet could help parkinson 's patients , to take a long - term treatment of Madopar .

  10. 方法:将40例肝肾阴虚型PD患者随机分为治疗组和对照组,治疗组联合服用美多巴和熄风定颤丸;

    Methods : Forty cases of PD with kidney deficiency type were selected and divided into the treatment group and the control group .

  11. 结论:吡贝地尔单用或联合复方旋多巴应用,吡贝地尔可以较好地改善早期PD患者的精神、情绪和睡眠等非运动症状;

    Conclusion : Both mono-use and combined use of piribedil can improve the mental status , depression emotion and sleep quality of early PD patients .

  12. 头部电针透穴疗法组与体针组能减少美多巴的副作用,与美多巴药物组比较(P<0.01),同时治疗组、体针组能减少美多巴的用量。

    Sometime , electroacupuncture Scalp Point-through-Point therapy group and acupuncture group could decreased side effect , contrasted acupuncture group ( P < 0.01 ), electroacupuncture Scalp Point-through-Point therapy group and acupuncture group could decreased medicine dose .

  13. 目的探讨立体定向注射6-羟基多巴(6-OHDA)建立帕金森病(PD)大鼠模型的方法及其稳定性。

    Objective To study the methods of establishing Parkinson 's disease ( PD ) rat model by stereotactic injection of6-hydroxydopamine ( 6-OHDA ) .

  14. 目的明确6-羟基多巴(6-OHDA)致多巴胺能神经元凋亡与氧化应激的关系,以及外源性超氧化物歧化酶(SOD)对多巴胺能神经元凋亡的保护作用。

    Objective To define oxidative stress and antagonistic action of the exogenous SOD in the apoptosis of the rat midbrain dopaminergic neuronal induced by 6-OHDA .

  15. 结论:抗帕颗粒可改善PD大鼠黑质纹状体TH阳性神经元的病理改变,抗帕颗粒联合美多巴治疗效果明显。

    Conclusion : Anti-Parkinson potion can decrease the lesions of the TH-positive neurons in substantia nigra and striatum in PD rats , and the group treated with both anti-Parkinson potion and Madopar is better .

  16. Fisher博士不相信大脑可以忽略对某人的厌恶&即使对婚姻危机中的夫妇大量注射的多巴氨,也于事无补。

    Dr Fisher does not believe that the brain could overlook distaste for someone & even if a couple in trouble could inject themselves with huge amounts of dopamine .

  17. 方法对16例家族性患者和10例散发性多巴反应性肌张力障碍患者进行病史采集、神经系统体格检查和CT或MRI检查,所得数据应用SPSS13.0软件进行统计分析。

    Methods Sixteen familiar DRD patients and 10 patients with sporadic DRD were studied by history taking , physical examination of nervous system and CT / MR scaning . The obtained data were statistical analyzed with SPSS 13.0 software in computer .

  18. 成功培养了人色素斑皮肤的黑色素细胞,细胞呈双极或者多级树突样,多巴染色和S-100蛋白免疫组化染色结果阳性。

    The human melanocytes in melasma skin were successfully cultured , and the cells were multi-dendritic . S-100 protein immunohistochemical staining and Dopa staining were positive .

  19. 长期服用多巴制剂的6例中晚期PD两侧积聚、BG/OC和BG/FC比值无明显差别,但均低于正常对照组(P<0.01)。

    In the moderate or advanced PD group , no significant differences were observed bilaterally , and the BG / OC and the BG / FC rates in this group was lower than those of the control .

  20. 帕金森病组予美多巴治疗1个月后复查,结果纹状体区NAA,NAA/肌酸有上升趋势(P<0.05)。

    The NAA and NAA / creatine of striatum in the PD group showed a tendency of increase after treated with Medopa for a month ( P < 0.05 ) .

  21. 正常雌鼠及6-羟基多巴型帕金森病雌鼠黑质听觉P50诱发电位的实验研究

    P50 auditory evoked potential in substantia nigra of normal female rats and female rat models of Parkinson disease induced by 6-hydroxydopamine

  22. 目的研究溴隐停及美多巴联合治疗创伤性脑外伤(TBI)后迁延性植物生存状态(PVS)的临床价值及使用范围。

    Objective To study the clinic application and value of the combination use of bromocriptine and madopa in the treatment of the posttraumatic persistent vegetative state ( PVS ) .

  23. 工程细胞可抵抗N甲基苯基吡啶(MPP+)对多巴脂能神经元的毒性损伤作用,与对照组比较,细胞数目增加了83.6%(为76倍,P<0.01)。

    Results The number of primary dopaminergic neurons protected by double-gene engineered cells increased at least by 2.8 times in comparison with the control cells ( P < 0.01 ), and those cells against MPP + toxicity increased by 83.6 % ( 7.6 times , P < 0.01 ) .

  24. 结论AR-JP具有发病年龄早、症状轻、进展缓慢、多巴制剂反应好等特征。

    Conclusions AR-JP is characterized by early age of onset , mild symptoms , slow progression and good response to levodopa .

  25. 目的:观察6-羟基多巴(6-OHDA)诱导PC12细胞凋亡的作用,探讨神经生长因子(NGF)对PC12细胞凋亡的保护作用。

    AIM : To investigate the protective effect of nerve growth factors ( NGF ) against PC12 cell apoptosis by observing the role of6-hydroxydopamine ( 6-OHDA ) in inducing apoptosis of PC12 cells .

  26. 目的本研究拟探讨慢性双侧丘脑底核脑深部电刺激器(STN-DBS)对患者多巴反应性以及所需多巴胺能药物剂量的影响。

    Objective To investigate the effect of bilateral subthalamic nucleus stimulation ( STN-DBS ) on the levodopa responsiveness and the change of levodopa-equivalent dose .

  27. 方法选择YahrⅡ期PD患者24例,随机分为两组,观察组12例给予低蛋白饮食加美多巴治疗,对照组12例单纯美多巴治疗。

    Method 24 cases with parkinson 's disease as Yahr ⅱ divided into two groups randomly . The experimental group were treated low - protein diet and taking madopar . The control group took Madopar .

  28. 方法:帕金森病(PD)大鼠80只,随机分为4组:对照组、美多巴组、抗帕颗粒组、抗帕颗粒联合美多巴组。

    Methods : 80 Parkinson disease ( PD ) rats were divided into 4 groups randomly , the control group ( treated with normal saline ), the group treated with Madopar , the group treated with anti-Parkinson potion , and the group treated with both anti-Parkinson potion and Madopar .

  29. PDD发生的相关因素按标准回归系数依次为性别、疾病严重程度、运动障碍严重程度、文化程度、是否应用多巴受体激动剂5项。

    The regression analysis showed that factors accounted for the occurrence of PDD were gender , the severity of PD , stage of patient 's motor impairment , education level and the use of dopamine agonists .

  30. 多巴一种胺基酸,C9H11NO4,由酪胺酸在肝脏中生成并在大脑中变为多巴胺。

    An amino acid , C9H11NO4 , formed in the liver from tyrosine and converted to dopamine in the brain .